Clinical Trial Update: The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating mesenchymal stem cells for the immune system in patients with amyotrophic lateral sclerosis (ALS) across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Polski Bank Komorek Macierzystych JSC (PBKM) | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN